person

Caroline F.

Country
France
Department
Neurology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
4
Sites with multiple studies

Has run more than one trial at 4 of 22 partner sites.

Specializations

Neuroimmunology

This investigator specializes in treating autoimmune neurological conditions, with particular emphasis on myelin oligodendrocyte glycoprotein antibody associated disease (MOG-AD). Their research explores innovative therapeutic approaches for preventing disease relapse following initial episodes.

  • MOG-AD treatment strategies
  • Autoimmune relapse prevention
  • Immunosuppressive therapy assessment

The investigator's work contributes to understanding long-term disease management in neuroimmunological conditions.

Neuromuscular Disorders

The investigator focuses on developing treatments for ocular myasthenia gravis, investigating novel therapeutic agents and their subcutaneous administration methods. Their work encompasses both targeted immunological approaches and innovative drug delivery systems.

  • Ocular myasthenia gravis therapeutics
  • Subcutaneous treatment delivery
  • Novel biological therapies

Their research aims to improve treatment outcomes in patients with neuromuscular junction disorders.

Clinical Immunotherapy

This researcher specializes in proactive treatment strategies for autoimmune conditions, particularly focusing on combination therapy approaches using corticosteroids and targeted biological agents. Their work emphasizes early intervention protocols in neuromuscular disorders.

  • Combination immunotherapy
  • Early intervention protocols
  • Disease progression prevention

The investigator's research explores standardized treatment approaches for improving long-term patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.